These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 11891477)
1. Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies. Ravizzini GC; Hanson MW; Shaw LK; Wong TZ; Hagge RJ; Pagnanelli RA; Jain D; Lima HS; Coleman RE; Borges-Neto S Nucl Med Commun; 2002 Mar; 23(3):203-8. PubMed ID: 11891477 [TBL] [Abstract][Full Text] [Related]
2. Comparative myocardial uptake of technetium-99 m sestamibi and technetium-99m tetrofosmin one hour after stress injection. Gremillet E; Champailler A Eur J Nucl Med; 1998 Nov; 25(11):1502-10. PubMed ID: 9799346 [TBL] [Abstract][Full Text] [Related]
3. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532 [TBL] [Abstract][Full Text] [Related]
4. Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice. Hambÿe AS; Delsarte P; Vervaet AM Nucl Med Commun; 2007 May; 28(5):383-90. PubMed ID: 17414888 [TBL] [Abstract][Full Text] [Related]
6. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats. Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487 [TBL] [Abstract][Full Text] [Related]
7. Efficiency of tetrofosmin versus sestamibi achieved through shorter injection-to-imaging times: A systematic review of the literature. Duvall WL; Case J; Lundbye J; Cerqueira M J Nucl Cardiol; 2021 Aug; 28(4):1381-1394. PubMed ID: 32236839 [TBL] [Abstract][Full Text] [Related]
8. Myocardial uptake characteristics of three 99mTc-labeled tracers for myocardial perfusion imaging one hour after rest injection. Manka-Waluch A; Palmedo H; Reinhardt MJ; Joe AY; Manka C; Guhlke S; Biersack HJ; Bucerius J Ann Nucl Med; 2006 Dec; 20(10):663-70. PubMed ID: 17385304 [TBL] [Abstract][Full Text] [Related]
9. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi. Borges-Neto S; Tuttle RH; Shaw LK; Smith WT; Jain D; Coleman RE; Whellan D Radiology; 2004 Jul; 232(1):58-65. PubMed ID: 15220493 [TBL] [Abstract][Full Text] [Related]
10. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. Acampa W; Cuocolo A; Sullo P; Varrone A; Nicolai E; Pace L; Petretta M; Salvatore M J Nucl Cardiol; 1998; 5(3):265-74. PubMed ID: 9669581 [TBL] [Abstract][Full Text] [Related]
11. The comparison of two gated SPET protocols: adenosine Tc-99m tetrofosmin and treadmill exercise Tc-99m MIBI. Dziuk MA; Pietrzykowski J; Canizales AL; Britton KE; Cholewa M Nucl Med Rev Cent East Eur; 2003; 6(1):11-5. PubMed ID: 14600927 [TBL] [Abstract][Full Text] [Related]
12. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability? Caner B; Beller GA Clin Cardiol; 1998 Apr; 21(4):235-42. PubMed ID: 9562932 [TBL] [Abstract][Full Text] [Related]
13. Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects. Giordano A; Meduri G; Marozzi P; Rubini G; Burroni L; Cappagli M Nucl Med Commun; 2003 Mar; 24(3):321-6. PubMed ID: 12612474 [TBL] [Abstract][Full Text] [Related]
14. The effect of imaging time, radiopharmaceutical, full fat milk and water on interfering extra-cardiac activity in myocardial perfusion single photon emission computed tomography. Peace RA; Lloyd JJ Nucl Med Commun; 2005 Jan; 26(1):17-24. PubMed ID: 15604943 [TBL] [Abstract][Full Text] [Related]
15. [Improved detection of fill-in using sublingual nitroglycerin in technetium-99m tetrofosmin exercise/rest single photon emission computed tomography one day protocol for old myocardial infarction]. Miyanaga H; Kunieda Y; Oguni A; Kamitani T; Kawasaki S; Takahashi T J Cardiol; 1999 Mar; 33(3):135-43. PubMed ID: 10225193 [TBL] [Abstract][Full Text] [Related]
16. Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease. Soman P; Taillefer R; DePuey EG; Udelson JE; Lahiri A J Am Coll Cardiol; 2001 Feb; 37(2):458-62. PubMed ID: 11216963 [TBL] [Abstract][Full Text] [Related]
17. Does P-glycoprotein have a role in the lung clearances of inhaled 99mTc-sestamibi and 99mTc-tetrofosmin? Cheow HK; Ruparelia P; Shankar S; Szczepura KR; Ballinger JR; Hartman NG; Chilvers ER; Peters AM Nucl Med Commun; 2009 Aug; 30(8):617-21. PubMed ID: 19474770 [TBL] [Abstract][Full Text] [Related]
18. Single-shot cardiorenal scintigraphy with 99mTc-tetrofosmin: a dynamic characterization at rest and during adenosine infusion. Fommei E; Bruselli L; Ripoli A; Gimelli A; Ghione S; Giorgetti A; Kush A; Tagliavia ID; Passino C; Marzullo P J Nucl Med; 2009 Aug; 50(8):1288-95. PubMed ID: 19617333 [TBL] [Abstract][Full Text] [Related]
19. Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing. Cuocolo A; Nicolai E; Soricelli A; Pace L; Nappi A; Sullo P; Cardei S; Argenziano L; Ell PJ; Salvatore M J Nucl Cardiol; 1996; 3(3):194-203. PubMed ID: 8805739 [TBL] [Abstract][Full Text] [Related]
20. Technetium-99m sestamibi and tetrofosmin myocardial single-photon emission tomography: can we use the same reference data base? Widding A; Hesse B; Gadsboll N Eur J Nucl Med; 1997 Jan; 24(1):42-5. PubMed ID: 9044875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]